What is CellResearch?
CellResearch Corp stands at the forefront of stem cell innovation, specializing in a diverse portfolio that includes umbilical cord lining stem cells, cord banking services, and advanced cosmeceuticals. The company's robust research and development pipeline is dedicated to pioneering treatments for a spectrum of challenging conditions, such as severe burns, chronic wounds, age-related macular degeneration, and various neurological disorders. Serving a broad market of healthcare providers, academic institutions, and individual patients, CellResearch also actively engages in contract research and strategic partnerships to accelerate advancements in regenerative medicine.
How much funding has CellResearch raised?
CellResearch has raised a total of $5.9M across 1 funding round:
Debt
$5.9M
Debt (2016): $5.9M with participation from Cordlife Group
Key Investors in CellResearch
Cordlife Group
Cordlife Group, a Singapore-based entity founded in 2001, provides comprehensive diagnostic services for families, including newborn metabolic screening and genetic testing, and is a participant in CellResearch's funding rounds.
What's next for CellResearch?
The substantial enterprise-level funding and recent strategic investment signal CellResearch's strong market position and its potential for accelerated growth and expanded research initiatives. This capital infusion is expected to fuel further development of its therapeutic applications and potentially broaden its market reach in the competitive stem cell sector. The company's focus on high-impact medical conditions suggests a trajectory aimed at significant clinical and commercial milestones.
See full CellResearch company page
